V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 310011094 | 310004147 | 1.58 | 57.5 | Curative (C) | 2017-11-28 | 2017-11-30 | BEAM | 2 | N | 310014478 | BEAM |
| 310011095 | 310004148 | null | 80.3 | Curative (C) | 2015-12-03 | 2015-12-09 | IVE | 2 | null | 310014483 | IVE |
| 310011096 | 310004160 | 1.7 | null | Disease modification (D) | 2018-05-28 | 2018-05-30 | BEAM | 02 | Y | 310014597 | BEAM |
| 310011098 | 310004170 | 1.72 | 14.8 | Curative (C) | 2017-01-24 | 2017-01-31 | Gemcitabine day 1&8 | N | null | 310014746 | GEMCITABINE |
| 310011099 | 310004177 | 1.68 | 67.5 | Palliative (P) | 2018-03-29 | 2018-03-29 | PEMBROLIZUMAB | 02 | N | 310014855 | PEMBROLIZUMAB |
| 310011100 | 310007745 | 1.64 | 53.6 | Palliative (P) | 2017-04-27 | 2017-05-16 | Brentuximab | 02 | N | 310014972 | BRENTUXIMAB |
| 310011101 | 310007747 | 1.49 | 52.6 | Disease modification (D) | 2017-06-25 | 2017-07-16 | Brentuximab | 2 | N | 310014991 | BRENTUXIMAB |
| 310011102 | 310004201 | 1.77 | 73.85 | Palliative (P) | 2017-09-21 | 2017-09-21 | PEMBROLIZUMAB | N | N | 310015002 | PEMBROLIZUMAB |
| 310011103 | 310004211 | 1.73 | 96.6 | Curative (C) | 2014-09-11 | 2015-02-07 | IVE | Y | N | 310015060 | IVE |
| 310011104 | 310007757 | 1.66 | 147.5 | Palliative (P) | 2016-10-10 | 2016-10-17 | Carboplatin + Liposomal Doxorubicin | N | N | 310015114 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011105 | 310004224 | null | 22 | Palliative (P) | 2019-04-19 | 2019-05-03 | PEMBROLIZUMAB | N | N | 310015295 | PEMBROLIZUMAB |
| 310011106 | 310004228 | 1.54 | 66 | Palliative (P) | 2019-06-16 | 2019-06-21 | Carboplatin + Liposomal Doxorubicin | 2 | Y | 310015328 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011107 | 310004244 | 1.7 | 57.7 | Curative (C) | 2015-12-28 | 2017-06-13 | BEAM | 2 | N | 310015424 | BEAM |
| 310011108 | 310004245 | 1.76 | 71.8 | Palliative (P) | 2015-11-15 | 2015-12-08 | PEMBROLIZUMAB | N | N | 310015428 | PEMBROLIZUMAB |
| 310011109 | 310004264 | 1.64 | 87.6 | Palliative (P) | 2019-03-12 | 2019-03-17 | Carboplatin + Liposomal Doxorubicin | N | N | 310015599 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011110 | 310004266 | 1.7 | 72.9 | Disease modification (D) | 2015-02-08 | 2016-05-27 | GEM-P | 02 | N | 310015652 | GEMCITABINE + PACLITAXEL |
| 310011111 | 310010651 | 1.7 | null | Curative (C) | 2017-05-16 | 2017-05-25 | BEAM | 02 | N | 310015670 | BEAM |
| 310011112 | 310004270 | 0 | 53.1 | Palliative (P) | 2016-11-03 | 2016-11-04 | GEMCITABINE | 02 | N | 310015687 | GEMCITABINE |
| 310011113 | 310004282 | 1.19 | 96.6 | Curative (C) | 2015-07-09 | 2015-07-30 | NB HRNBL-1 Isotretinoin | 02 | N | 310015863 | NOT MATCHED |
| 310011114 | 310004287 | 1.7 | 74.2 | Palliative (P) | 2015-04-10 | 2015-04-23 | Carboplatin + Liposomal Doxorubicin | Y | null | 310015911 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011115 | 310004304 | null | 96.6 | Palliative (P) | 2014-10-11 | 2014-10-11 | BEAM | 02 | N | 310016112 | BEAM |
| 310011116 | 310004311 | null | 53.6 | Palliative (P) | 2016-02-05 | 2016-02-11 | PEMBROLIZUMAB | N | N | 310016142 | PEMBROLIZUMAB |
| 310011117 | 310004319 | null | 25.2 | Curative (C) | 2019-12-06 | 2019-12-07 | ALL UKALL2011 Maintenance C4 | 02 | N | 310016231 | NOT MATCHED |
| 310011118 | 310004327 | 1.56 | 68.1 | Curative (C) | 2014-07-05 | 2014-07-06 | LEAM | 02 | N | 310016303 | LEAM |
| 310011119 | 310004332 | 1.58 | 70.8 | Palliative (P) | 2014-11-13 | 2014-12-08 | Carboplatin + Liposomal Doxorubicin | N | N | 310016377 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011121 | 310010664 | 1.83 | 108.7 | Adjuvant (A) | 2012-07-16 | 2016-10-12 | LEAM | 2 | N | 310016633 | LEAM |
| 310011122 | 310004365 | 1.71 | 70.6 | Disease modification (D) | null | 2016-03-19 | LEAM | 2 | N | 310016833 | LEAM |
| 310011123 | 310007828 | null | 55.5 | Palliative (P) | null | 2018-11-08 | Brentuximab | 02 | N | 310016840 | BRENTUXIMAB |
| 310011125 | 310004394 | 1.78 | 85.8 | Curative (C) | 2012-11-15 | 2015-10-15 | GEM-P | 02 | null | 310017080 | GEMCITABINE + PACLITAXEL |
| 310011126 | 310007851 | 1.61 | 62 | Curative (C) | 2018-01-29 | 2018-02-05 | LEAM | N | N | 310017252 | LEAM |
| 310011127 | 310004415 | 1.84 | 95 | Curative (C) | 2014-07-23 | 2014-07-27 | IVE | 2 | N | 310017276 | IVE |
| 310011128 | 310004420 | 1.75 | 101.7 | Curative (C) | 2019-05-05 | 2019-05-05 | ALEMTUZUMAB + CARMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | N | N | 310017284 | NOT MATCHED |
| 310011130 | 310004437 | 1.81 | 64 | Neo-adjuvant (N) | 2017-10-27 | 2017-11-04 | BEAM | 02 | N | 310017385 | BEAM |
| 310011131 | 310004445 | 1.64 | 59.5 | Palliative (P) | 2013-07-28 | 2016-06-03 | GEMCITABINE | N | N | 310017432 | GEMCITABINE |
| 310011132 | 310004447 | 1.72 | null | Curative (C) | 2017-05-11 | 2017-05-11 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 310017474 | CISPLATIN + GEMCITABINE |
| 310011133 | 310004475 | 1.69 | 94.3 | Disease modification (D) | 2019-10-04 | 2019-10-04 | LEAM | 02 | N | 310017644 | LEAM |
| 310011134 | 310004482 | null | 86 | null | 2017-11-22 | 2018-04-08 | GEM-P | N | N | 310017721 | GEMCITABINE + PACLITAXEL |
| 310011135 | 310009721 | 1.84 | 82.4 | Palliative (P) | 2018-07-11 | 2018-07-16 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 310017864 | GEMCITABINE |
| 310011136 | 310004506 | 1.7 | 73.4 | Palliative (P) | 2016-01-01 | 2016-01-07 | GEMCITABINE | N | N | 310017871 | GEMCITABINE |
| 310011138 | 310004512 | 1.83 | 59.75 | Palliative (P) | 2014-11-07 | 2014-11-07 | Carboplatin + Liposomal Doxorubicin | N | N | 310017889 | CARBOPLATIN + LIPOSOMAL DOX |
| 310011139 | 310007912 | 1.58 | 78.4 | Palliative (P) | 2010-02-16 | 2015-02-20 | Brentuximab | 2 | N | 310017898 | BRENTUXIMAB |
| 310011140 | 310004517 | 1.78 | 93.9 | Curative (C) | 2017-01-17 | 2017-01-17 | IVE | Y | N | 310017909 | IVE |
| 310011141 | 310004525 | null | null | Adjuvant (A) | 2018-04-11 | 2018-04-12 | BEAM | 2 | N | 310017972 | BEAM |
| 310011142 | 310004538 | 1.58 | 63 | Curative (C) | null | 2018-05-27 | BEAM | null | null | 310018037 | BEAM |
| 310011143 | 310004542 | 1.66 | 50.1 | Curative (C) | 2018-11-10 | 2018-11-10 | BEAM | 02 | N | 310018046 | BEAM |
| 310011144 | 310004547 | null | 85.75 | Palliative (P) | null | 2016-06-23 | Brentuximab | N | N | 310018070 | BRENTUXIMAB |
| 310011145 | 310004549 | 1.75 | 70.2 | Palliative (P) | 2018-03-08 | 2018-03-18 | GEM-P | N | N | 310018083 | GEMCITABINE + PACLITAXEL |
| 310011146 | 310004552 | 1.54 | 90 | Palliative (P) | 2018-05-13 | 2018-05-27 | Mini BEAM | N | N | 310018091 | BEAM |
| 310011147 | 310007933 | 1.55 | 67 | Palliative (P) | 2016-12-11 | 2016-12-11 | PEMBROLIZUMAB | N | N | 310018115 | PEMBROLIZUMAB |
| 310011148 | 310007934 | null | 21.25 | Curative (C) | null | 2016-09-10 | Gemcitabine 1000mg/m2 D1 8 15 | 02 | N | 310018121 | GEMCITABINE |